請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35208
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫 | |
dc.contributor.author | Yen-Yi Lu | en |
dc.contributor.author | 盧嬿伊 | zh_TW |
dc.date.accessioned | 2021-06-13T06:44:06Z | - |
dc.date.available | 2005-08-04 | |
dc.date.copyright | 2005-08-04 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-07-29 | |
dc.identifier.citation | Anderson, D.M., Lyman, S.D., Baird, A., Wignall, J.M., Eisenman, J., Rauch, C., March, C.J., Boswell, H.S., Gimpel, S.D., Consman, D., Williams, D.E. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63, 235-243. (1990).
Antonysamy, M.A., Thomson, A.W. Flt3 ligand (FL) and its influence on immune reactivity. Cytokine 12, 87-100. (2000). Asselin-Paturel, D., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, D., Vicari, A., O’Garra, A., Biron, C., Briere, F., Trinchieri, G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150. (2001). Barouch, D.H., Letvin, N.L., Seder, R.A. The role of cytokine DNAs as adjuvants for optimizing cellular immune responses. Immunol. Rev. 202, 266-274. (2004). Banchereau, J., Schuler-Thurner, B., Palucka, A.K., Schuler, G. Dendritic cells as vectors for therapy. Cell 106, 271-274. (2001). Brasel, K., McKenna, H.J., Morrissey, P.J., Charrier, K., Morris, A.E., Lee, C.C., Williams, D.E., Lyman, S.D. Hematologic effects of flt3 ligand in vivo in mice. Blood 88, 2004-2012. (1996). Brasel, K., Maraskovsky, E., Pulendran, B. Preferential expansion of myeloid-type dendritic cells in vivo after administration of GM-CSF into mice: a comparative analysis with Flt3 ligand generated dendritic cells. Blood 90, 170. (1997). Brasel, K., De Smedt, T., Smith, J.L., Maliszewski, C.R. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96,3029-3039. (2000). Brawand, P., Fitzpatrick, D.R., Greenfield, B.W., Brasel, K., Maliszewski, C.R., Smedt, T.D. Murine plasmacytoid pre-dendritic cells generated from flt3 ligand-supplemented bone marrow culture are immature APCs. J.Immunol. 169, 6711-6719. (2002). Birg, F., Rosnet, O., Carbuccia, N., Birnbaum, D. The expression of FMS, KIT and FLT3 in hematopoietic malignancies. Leukemia Lumphoma 13, 223-227. (1994). Bjorck,P. Isolation and characterization of plasmacytoid dendritic cells from Flt3L and granulocyte-macrophage colony-stimulatory factor-treated mice. Blood 98, 3520-3526. (2001). Blomberg, J., Lycke, E., Ahlfors, K., Johnsson, T., Wolontis, S., von Zeipel, G. Letter: New enterovirus type associated with epidemic of aseptic meningitis and –or hand, foot, and mouth disease. Lancet 2, 112.(1974). Brown, B.A., Oberste, M.S., Alexander, Jr.J.P., Kennett, M.L., Pallansch, M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73, 9969-9975. (1999). Broxmeyer, H., Lu, L., Cooper, S., Ruggieri, L., Li, Z., Lyman, S. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. Exp. Hematol. 23, 1121-1129. (1995). Burgess, A.W., Metcalf, D. The Nature and action of granulocyte-macrophage colony stimulating factors. Blood 56, 947-958. (1980). Chang, L.Y., Huang, Y.C., Lin, T.Y. Fulminant neurogenic pulmonary oedema with hand, foot and mouth disease. Lancet 352, 367-368. (1998). Chow, M., Baltimore, D. Isolated poliovirus capsid protein VP1 induces a neutraliaing response in rat. Proc. Natl. Acad. Sci. USA 79, 7518-7521. (1982). Chow, M.H., Huang, W.L., Chi, W.K., Chu, Y.D., Tao, M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis C surface antigen and interleukin-2. J. Virol. 71, 169-178. (1997). Chow, M.H., Huang, W.L., Chi, W.K., Chu, Y.D., Tao, M.H. Development of Th1 and Th2 populations and the nature of immune response to hepatitis B virus DNA vaccine can be modulated by codelivary of various cytokine genes. J. Immunol. 160, 1320-1329. (1998). Chumakov, K.M., Norwood, L.P., Parker, M.L.,Dragunsky, E.M., Ran, Y.X., Levenbook, I.S. RNA sequence variants in live poliovirus vaccine and their relation to virulence. J. Virol. 66, 966-970. (1992). Clin, M.J., Golde, D.W. Production of colony-stimulating activity by human lymphocytes. Nature 248, 703-704. (1974). Collier, L., Oxford, J. Human Virology: a text for students of medicine, dentistry, and microbiology. 2nd Ed. Oxford University Press Inc., New York. 121-129. (2000). Daro, E., Pulendran, B., Brasel, K., Teepe, M., Pettit, D., Lynch, D.H., Vremec, D., Robb, L., Shortman, K., McKenna, H.J., Maliszewski, C.R., Maraskovsky, E. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J Immunol. 165, 49-58. (2000). Galy, A., Travis, M., Cen, D., Chen, B. Human T, B, nature killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3, 459-471. (1995). Geissler, M., Egsien, A., Tokushige, K., Wands, J.R. Enhancement of cellular and humoral immuneresponses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158, 1231-1237. (1997). Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X.L., Trinchieri, G., O’Garra, A., Liu, Y.J. The development of murine plasmacytoid dendritic cell precursor is differentially regulated by flt3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953-958. (2002). Godfrey, D.I., Zlotnik, A., Suda, T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J. Immunol. 149, 2281-2285. (1992). Greenberg, P.L., Mara, B., Heller, P. Marrow adherent cell colony-stimulating activity production in acute myeloid leukemia. Blood 52, 362-378. (1978). Gromeier, M., Wimmer, E., Gorbalenya, A.E. Genetics, pathogenesis and evolution of Picornaviruses. In Domingo, E., Webster, R., Holland, J., Eds., Origin and Evolution of Viruses, Academic Press, New York, 287-344. (1999). Hannum, C., Culpepper, J., Campbell, D., McClanahan, T., Zurawski, S., Bazan, J.F., Kastelein, R., Hudak, S., Wagner, J., Mattson, H., Luh, J., Duda, G., Martina, N., Peterson, D., Manon, S., Shanafelt, A., Muench, M., Kelner, G., Namikawa, R., Rennick, D., Roncarolo, M.G., Zlotnic, A., Rosnet, O., Dubreuil, P., Birnbaum, D., Lee, F. Ligand for flt3/flk2 receptor regulates growth of hematopoietic stem cells and its encoded by variant RNAs. Nature 68, 643-648. (1994). Hoatlin, M.E. Kew, O.M., Renz, M.E. Regions of poliovirus protein VP1 produced in Escherichia Coli induce neutralizing antibodies. J. Virol. 61, 1442-1447. (1987). Hogle, J.M., Chow, M., Filman, D.M. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229, 1358-1365. (1985). Hu, Y.C., Hsu, J.T.A., Huang, J.H., Ho, M.S., Ho, Y.C. Formation of enterovirus-like particle aggregates by recombinant baculoviruses P1 and 3CD in insect cells. Biotechnol. Lett. 25, 919-925. (2003). Hunte, B.E., Hudak, S., Campbell, D., Xu, Y., Rennick, D. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J. Immunol. 156, 489-496. (1996). Icenogle, J.P., Minor, P.D., Ferguson, M., Hogle, J.M. Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J. Virol. 60, 297-301. (1986). Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Steinman, R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J.Exp.Med. 176, 1693-1702. (1992). Iwasaki, A., Steierholm, B.J.N., Chan, A.K., Berinstein, N.L., BarBer, B.H. Enhancement CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158. 4591-4601. (1997). Jacobsen, S.E.W., Okkenhaug, C., Myklebust, J., Veiby, O.P., Lyman, S.D. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukn 11, IL-12, and other hematopoietic growth factors. J. Exp. Med. 181, 1357-1363. (1995). Jacobsen, S.E., Veiby, O.P., Myklebust, J., Okkenhaug, C., Lyman, S.D. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha. Blood 87, 5016-5026. (1996). Kaech, S.M., Wheery, E.J., Ahmed, R. Effector and memory T cell differentiation: implication for vaccine development. Nat. Rev. Immunol. 2, 251-262. (2002). Kataoka, K., McGhee, J.R., Kobayashi, R., Fujihashi, K., Shizukuishi, S., Fujihashi, K. Nasal flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity. J. Immunol. 172, 3612-3619. (2004). Knudtzon, S., Mortensen, B.T., Growth stimulation of human bone marrow cells in agar culture by vascular cells. Blood 46, 937-943. (1975). Lin, T.Y., Chang L.Y., Hsia S.H., Huang Y.C., Chiu, C.H., Hsueh, C., Shih, S.R., Liu, C.C., Wu, M. H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34, 52-57. (2002). Lin, T.Y., Twu, S.J., Ho, M.S., Chang, L.Y., Lee, C.Y. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis. 9, 291-293. (2003). Lu, C.Y., Lee, C.Y., Kao, C.L., Shao, W.Y., Lee, P.I., Twu, S.J., Yeh, C.C., Lin, S.C., Shih, W.Y., Wu, S.I., Huang, L.M. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J. Med. Virol. 67, 217-223. (2002). Lyman, S.D., James, L.,Vanden, B.T., de Vries, K., Brasel, K., Gliniak, B., Hollingsworth, L.T., Picha, K.S., McKenna, H.J., Splett, R.R., Fletcher, F.A., Maraskovsky, E., Farrah, T., Foxworthe, D., Williams, D.E., Beckmann, M.P. Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75, 1157-1167. (1993). Lyman, S.D., James, L., Zappone, J., Sleath, P.R., Beckmann, M.P., Bird, T. Characterization of the protein encoded by flt3 (flk2) receptor-like tyrosine kinase gene. Oncogene 8, 815-822. (1993). Lyman, S.D., James, L., Johnson, L., Brasel, K., de Vries, P., Escobar, S.S., Downey, H., Splett, R.R., Beckmann, M.P., McKenna, H.J. Cloning of the human homologue of the murine flt3 ligand : a growth factor for early hematopoietic protenitor cells. Blood 83, 2785-2801. (1994). Lyman, S.D., Brasel, K., Rousseau, A.M., Wiliams, D.E. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells 12, 99-107. (1994). Lyman, S.D., James, L., Escobar, S., Downy, H., de Vries, K., Braxel, K., Stocking, K., Beckmann, M.P., Copeland, N.G., Cleveland, L.S., Jenkins, N.A., Belmont, J.W., Davison, B. Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 10, 149-157. (1995). Mackarehtschian, K., Hardin, J.D., Moore, K.A., Boast, S., Goff, S.P., Lemischka, I.R. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3, 147-161. (1995). Maraskovsky, E., Brasel, K., Teepe, M., Roux, E., Shortman, K., Lyman, S.D., McKenna, H.J. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J.Exp. Med. 184, 1953-1962. (1996). Maroc, N., Rottapel, R., Rosnet, O., Marchetto, S., Lavezzi, C., Mannoni, P., Birnbaum, D., Dubreuil, P. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 8, 909-918. (1993). Martin, P., del Hoyo, G.M., Anjuere, F., Arias, C.F., Vargas, H.H., Fernandez-L, A., Parrillas, V., Ardavin, C. Characterization of a new subpopulation of mouse CD8B220 dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100, 383-389. (2002). Matthews, W., Jordan, D.T., Gavin, M., Jerkins, N.A., Copeland, N.G., Lemischka, I.R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA 88,9026-9030. (1991). Matthews, W., Jordan, C.T., Wiegand, G.W., Pardoll, D., Lemischka, I.R. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65, 1142-1152. (1991). Matzinger, P., Guerder, S. Does T cell tolerance require a dedicated antigen-presenting cell? Nature 338, 74-76. (1989). McMinn, P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26, 91-107. (2002). McNiece, I.K., Langley, K.E., Zsebo, K.M. The role of recombinant stem cell factor in early B cell development. J. Immunol. 146, 3785-3790. (1991). Meierhoff, G., Dehmel, U., Gruss, H.J., Rosnet, O., Birnbaum, d., Quentmeier, H., Dirks, W., Drexler, H.G. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 9, 1368-1372. (1995). Metcalf, D. Hemopoietic Colonies. In Vitro Cloning of Normal and Leukemic Cells. Berlin, Springer Verlag. (1977). Metcalf, D. Hemopoietic colony stimulating factors, in Baserga R(ed): Tissue Growth Factors. Springer, New York, (1980). Metcalf, D. Hematopoietic regulators: Redundancy or subtlety? Blood 82, 3515-3525. (1993). Minor, P.D., Schild, G.C., Bootman, J., Evans, D.M.A., Ferguson, M., Reeve, P., Spitz, M., Stanway, G., Cann, A.J., Hauptmann, R., Clarke, L.D., Mountford, R.C., Almond, J.W. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 301, 674-679. (1983). Minor, P.D., Evans, D.M.A., Ferguson, M., Schild, G.C., Almond, J.W. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J.Gen. Virol. 65, 1159-1165. (1985). Moore, A.C., Kong, W.P., Chakrabarti, B.K., Nabel, G.J. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J. Virol. 76, 243-250. (2002). Moore, T.A., Zlotnik, A. Differential effects of FLK-2/FLT-3 ligand and stem cell factor on murine thymic progenitor cells. J. Immunol. 26, 1504-1510. (1997). Muench, M.O., Roncarolo, M.G., Menon, S., Xu, Y., Kastelein, R., Zurewski, S., Hannum, C.H. , Culpepper, J., Lee, F., Namikawa, R. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85, 963-972. (1995). Muir, P., Ras, A., Klapper, P.E., Cleator, G.M., Korn, K., Aepinus, C., Fomsgaard, A., Palmer, P., Samuelsson, A., Tenorio, A., Weissbrich, B., Loon, A.M. Multicenter quality assessment of PCR methods for detection of enteroviruses. J. Clin. Microbiol. 37, 1409-1414. (1999). Nagy, G., Takatsy, S., Kukan, E., mihaly, I., Domok, I. Virological diagnosis of enterovirus 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 71, 217-227. (1982). Namikawa, R., Muench, M.O., de Vries, J.E., Roncarolo, M.G. The FLK2/FLT3 ligand synergizes with inerleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 87, 1881-1890. (1996). Noguchi, Y., Wada, H., Marino, M.W., Old, L.J. Regulation of IFN-γ production in granulocyte/macrophage colony-stimulating factor-deficient mice. Eur. J. Immunol. 28, 3980-3988. (1998). Oberste, M.S., Maher, K., Kilpatrick, D.R., Pallansch, M.A. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 73, 1941-1948. (1999). Oberste, M.S., Maher, K., Kilpatrick, D.R., Flemister, M.R., Brown, B.A., Pallansch, M.A. Typeing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37, 1288-1293. (1999). Ou-Yang, P., Hwang, L.H., Tao, M.H., Chiang, B.L., Chen, D.S. Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein expressing DNA vaccine: role of dendritic cells. J. Med. Virol. 66, 320-328. (2002). Pardoll, D.M. Spinning molecular immunology into successful immunotherapy. Nat. Rev. Immunol. 2,227-238. (2002). Pulendran, B., Smith, J.L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., Maliszewski, C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. U S A. 96, 1036-41. (1999). Racaniello, V.R. Picornavirus: The viruses and their replication. In Knipe, D.M., Howley, P.M., et al. Eds., Fields Virology 4th Edn., Lippincott Williams, Wilkins, Philadelphia, 685-722. (2001). Rosnet, O., Mattei, M.G., Marchetto, S., Birnbaum, D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics. Genomics 9, 380-385. (1991). Rosnet, O., Marchetto, S., de Lapeyriere, Ol, Birnbuam, D. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSFIR family. Oncogene 6,1641-1650.(1991). Rosnet, O., Schiff, C., Pebusque, M.J., Marchetto, S., Tonnelle, C., Toiron, Y., Birg, F., Birnbaum, D. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82, 1110-1119. (1993). Rueckert, R.R., Dunker, A.K., Stoltzfus, C.M. The structure of mouse-Elberfeld virus: a model. Porc. Natl. Acad. Sci. USA 62, 912-919. (1969). Sallusto, F., Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by ganulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118. (1994). Schuler, G., Schuler-Thurner, B., Steinman, R.M. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15, 138-147. (2003). Shurin, M.R., Pandharipande, P.P., Zorina, T.D., Haluszczak, D., Subbotin., V.M., Hunter, O., Brumfield, A., Storkus, W.J., Maraskovsky, E., Lotze, M.T. FLT3 ligand induces the generation of functionally active dendrtitic cells in mice. Cell Immunol. 179, 174-184. (1997). Small, D., Levenstein, M., Kim, E., Carow, C., Amin, S., Rockwell, P., Witte, L., Burrow, C., Ratajczak, M.Z., Gewirtz, a.M., Civin, C.L. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34-human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl. Acad. Sci. USA 91, 459-463. (1994). Sin, J.I., Kim, J.J., Boyer, J.D., Cicarelli, R.B., Higgins, T.J. Weiner, D.B. In vivo modulation of vaccine-induced immune response toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simples virus type 2 mouse model. J. Virol. 73, 501-509. (1999). Steinman, R.M. The dendritic cell system and its role in immuogenicity. Ann. Rev. Immuol. 9, 271-296. (1991). Stein, J., Borzillo, G.V., Rettenmier, C.W. Direct stimulation of cell expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. Blood 76, 1308-1314. (1990). Samuda, G.M., Chang, W.K., Yeung, C.Y., Tang, P.S. Monoplegia caused by enterovirus 71: an outbreak in Hong Kong. Pediatr. Infect. Dis. J. 6, 206-208. (1987). Schmidt, N.J., Lennette, E.H. and Ho, H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129, 304-309. (1974). Shah, R.G., Caporale, L.H., Moore, M.A.S. Characterization of colony-stimulating activity produced by human monocytes and phytohemagglutinin-stimulated lymphocytes. Blood 50, 811-821. (1977). Shindarov, L.M., Chumakov, M.P., Voroshilova, M.K., Bojinov, S., Vasilenko, S.M., Iordanov, I. et al. Epidemiological, clinical and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23, 284-295. (1979). Tagaya, I., Tachibana, K. Epidemic of hand, foot and mouth disease in Japan, 1972-1973: Difference in epidemiologic and virologic features from the previous one. Jpn. J. Med. Sci. Biol. 28, 231-234. (1975). Tsuji, K., Zsebo, K.M., Ogawa, M. Enhancement of murine blast cell colony formation in culture by recombinant rat stem factor ligand for c-kit. Blood 78, 1223-1229. (1991). van de Werf, S., Wychowski, C., Bruneau, P., Blondel, B., Crainic, R., Horodiceanu, F., Girard, M. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc. Natl. Acad. Sci USA 80, 5080-5084. (1983). Veiby, O.P., Jacobsen, F.W., Cui, L., Lyman, S.D., Jacobsen, S.E. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J. Immunol. 157, 2953-2960. (1997). Viney, J.L., Mowat, A.M., O'Malley, J.M., Williamson, E., Fanger, N.A. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol. 160, 5815-25. (1998). Westermann, J., Nguyen-Hoai, T., Mollweide, A., Richter, G., Schmetzer, O., Kim, H.J., Blankenstein, Th., Dorken, B., Pezzutto, A. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization. Gene Therapy 11, 1048-1056. (2004). Wiegers, K.J., Dernick, R. Binding site of neutralizing monoclonal antibodies obtained after in vivo priming with purified VP1 of poliovirus type 1 is located between amino acid residues 93 and 104 of VP1. Virology 157, 248-251. (1987). Wu, C.N., Lin, Y.C., Fann, C., Liao, N.S., Shin, S.R., Ho, M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20, 895-904. (2002). Wu, S.C., Liu,C.C., Lian, W.C. Optimization of microcarrier cell culture process for the inactived enterovirus type 71 vaccine development. Vaccine 22, 3858-3824. (2004). Wychowski, C., Werf, S.V.D., Siffert, O., Crainic, R., Bruneau, P., Girard, M. A poliovirus type 1 neutralization epitope is located within amino acid residues 93-104 of viral capsid polypeptide VP1. EMBO J. 2, 2019-2024. (1983). Zeigler, F.C., Bennett, B.D., Jordan, C.T., Spencer, S.D., Baumhueter, S., Carroll, K.J., Hooley, J., Bauer, K., Matthews, W. Cellular and molecular characterization of the role of the flk-2/flt3 receptor tyrosine kinase in hematopoietic stem cells. Blood, 84, 2422-2430. (1994). Zheng, Z.H., He, P.J. Caueffield, D., Neumann, M., Specter, S., Baker, C.C., Bankowski, M.J. Enterovirus 71 isolated from China is serologically similar to the prototype EV71 BrCr strain but differs in the 5’-noncoding region. J. Med. Virol. 47, 161-167. (1995). 林才宇 腸病毒71型之VP1蛋白質及DNA在小鼠誘發免疫反應之研究 碩士論文 國立台灣大學口腔生物科學研究所 (2003). 李溫雅 腸病毒71型結構蛋白之DNA疫苗的免疫性及對新生幼鼠的被動保護效果 碩士論文 國立台灣大學流行病學研究所 (2002). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35208 | - |
dc.description.abstract | 腸病毒71型(EV71)是在世界各地腸病毒的感染中,造成高致死率以及嚴重的神經方面疾病最主要的病毒。由於至今仍無有效的方法治療受腸病毒71型感染的病患,發展並增強DNA疫苗的效用以提高體內免疫反應,對於預防腸病毒71型的感染也許是有效的方法。DNA疫苗所引起的免疫反應是由抗原呈現細胞(APC),尤其是樹突細胞,呈現抗原開始。Flt3L與GM-CSF這兩種細胞激素對於樹突細胞的發育以及生長都扮演了相當重要的角色。在本研究中,使用EV71 vp1質體合併使用Flt3L或GM-CSF細胞激素的基因作為佐劑,經由鼻腔的途徑給予質體以致敏Balb/c小鼠,並觀察後續所誘發之免疫反應。本研究提出經由黏膜(鼻腔內)途徑給予小鼠vp1質體伴隨Flt3L佐劑使用時,可以誘導出小鼠體內抗VP1特異性IgA抗體的產生。經由vp1與Flt3L致敏之小鼠體內血清中之IgA含量明顯的高於未經處理的組別。本篇研究的結果指出,合併使用Flt3L基因與腸病毒71型vp1基因持續致敏小鼠,可以增加小鼠體內特異性抗體的產生,並且引發較強的黏膜免疫反應,提供保護的機制以減少受到腸病毒之感染機率。 | zh_TW |
dc.description.abstract | Enterovirus 71(EV71) has been the most important enterovirus to cause the high fatality and severe neurological diseases. Due to the fact that there is still no appropriate treatment to remedy patients after they are infected, efficient DNA vaccine might be an effective approach to induce immune response against EV71 infections. Immune responses generated by DNA vaccination are initiated by antigen-presenting cells (APCs), especially dendritic cells. Both FMS-like tyrosine kinase 3 ligand(Flt3L) and granulocyte-macrophage colony stimulating factor(GM-CSF) proteins play crucial roles in the development and expansion of dendritic cells, the professional APCs. In this study, we immunized female Balb/c mice with EV71 vp1 plasmid DNA and co-immunize with or without Flt3L or GM-CSF genes as the adjuvant genes by intranasal administration. We demonstrated that immunization with vp1 plasmid DNA accompanies with Flt3L adjuvant gene via mucosal (intranasal) route could induce higher anti-VP1 specific IgA production. Balb/c mice immunized with vp1 and Flt3L plasmids had much higher seral IgA titer than that of untreated group. Our result indicated that the combination of Flt3L gene with enteroviral vp1 gene immunization enhanced antibody production and triggered a better mucosa immune response for protection from enteroviral infection. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T06:44:06Z (GMT). No. of bitstreams: 1 ntu-94-R92450002-1.pdf: 1554232 bytes, checksum: 4ed6103130a0af7e175c406d86da6baa (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | 誌謝 ………………………………………………I
Abstract ……………………………………………II 中文摘要 ……………………………………………III 論文目錄 ……………………………………………IV 第一章 緒論 ………………………………………1 第二章 實驗材料與方法 ……………………………18 第三章 實驗結果 ……………………………………38 第四章 結論與討論 …………………………………45 圖表 ………………………………………………52 參考文獻 ……………………………………………63 附錄 …………………………………………………73 | |
dc.language.iso | zh-TW | |
dc.title | 利用Flt3L或GM-CSF基因增強腸病毒DNA疫苗誘發之黏膜免疫反應 | zh_TW |
dc.title | Enhancement of mucosal enteroviral DNA vaccine immune response with co-immunization with Flt3L or GM-CSF gene | en |
dc.type | Thesis | |
dc.date.schoolyear | 93-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張鑾英,吳漢忠 | |
dc.subject.keyword | 疫苗,腸病毒, | zh_TW |
dc.subject.keyword | vacciine,enterovirus,Flt3L,GM-CSF, | en |
dc.relation.page | 85 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2005-07-29 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 1.52 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。